The influence of retinal oxygen saturation and choroidal volume on postoperative outcomes in patients with epiretinal membrane.


Journal

Acta ophthalmologica
ISSN: 1755-3768
Titre abrégé: Acta Ophthalmol
Pays: England
ID NLM: 101468102

Informations de publication

Date de publication:
May 2022
Historique:
received: 31 01 2021
accepted: 17 06 2021
pubmed: 17 8 2021
medline: 15 4 2022
entrez: 16 8 2021
Statut: ppublish

Résumé

To investigate the effects of vitrectomy (Vy) with or without same time cataract surgery and membrane plus internal limiting membrane peeling (MP+ILMP) on retinal oxygenation and choroidal volume and their role on postoperative outcome. Thirty-two eyes were included in this prospective clinical study. All patients received 23 gauge Vy+MP+ILMP without endotamponade. Additional cataract surgery was performed in 14 patients. Follow-up visits were scheduled at day 1, week 1, month 1 and month 3. At each visit, best corrected visual acuity (BCVA) using ETDRS charts (except at day 1), oxygenation of retinal vessels using the Oxymap T1, and optical coherence tomography (OCT, Heidelberg Spectralis) was performed. Mean BCVA increased significantly from 73 ± 11 letters to 77 ± 7 letters at month 3 (p = 0.02). Mean central retinal thickness (CRT) decreased from 456 ± 84 µm at baseline to 418±58µm (p = 0.01 baseline versus month 3). In the cataract surgery group, CRT was higher at month 3 than in the group without (400 ± 58 µm versus 441 ± 51 µm; p = 0.007). There was no statistically significant difference in choroidal volume or oxygenation of retinal vessels between groups (additional cataract surgery versus vitrectomy alone). Oxygenation of retinal arteries tended to decrease at day 1 followed by an increase, but the changes did not reach the level of significance (p = 0.29 baseline versus month 3). Oxygenation of retinal veins increased significantly (p = 0.02 baseline versus month 1; p = 0.04 baseline versus month 3, accordingly). There was a significant negative correlation (Spearman correlation coefficient rs = -0.35, p = 0.047) between visual acuity and oxygenation of retinal veins at month 3. No statistically significant correlation was found between CRT and oxygenation of neither retinal arteries nor veins. Choroidal volume (CV) of the central mm did not change significantly during the study period (baseline: 0.203 ± 0.04 mm Oxygen saturation may affect the visual acuity outcome but not the CRT in patients after vitrectomy for epiretinal membrane. Choroidal thickness had no statistically significant influence on the study outcomes. Further studies are needed to evaluate if the measurement of retinal oxygenation may be helpful in the decision for surgery.

Identifiants

pubmed: 34396704
doi: 10.1111/aos.14966
pmc: PMC9291286
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e743-e752

Informations de copyright

© 2021 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.

Références

Invest Ophthalmol Vis Sci. 2012 Apr 24;53(4):2274-80
pubmed: 22427584
Invest Ophthalmol Vis Sci. 2012 Apr 02;53(4):1729-33
pubmed: 22395877
Ophthalmology. 1985 Apr;92(4):503-6
pubmed: 2582329
Retina. 2015 Mar;35(3):487-91
pubmed: 25322467
Retina. 2008 Mar;28(3):410-9
pubmed: 18327132
Clin Ophthalmol. 2017 Apr 21;11:759-765
pubmed: 28461738
Am J Ophthalmol. 2014 Sep;158(3):455-9.e1
pubmed: 24875000
Acta Ophthalmol. 2016 Feb;94(1):41-7
pubmed: 26310901
Klin Monbl Augenheilkd. 1980 Jul;177(1):24-30
pubmed: 7453035
Invest Ophthalmol Vis Sci. 2012 Jun 14;53(7):3592-7
pubmed: 22589432
Invest Ophthalmol Vis Sci. 2012 Aug 13;53(9):5433-42
pubmed: 22786895
Retina. 2018 Oct;38(10):1968-1976
pubmed: 29746411
Acta Ophthalmol. 2018 Aug;96(5):e614-e618
pubmed: 29488329
Ophthalmologe. 2008 Aug;105(8):753-60
pubmed: 18369639
Retina. 2021 Mar 1;41(3):510-515
pubmed: 32568990
Br J Ophthalmol. 2012 Apr;96(4):560-3
pubmed: 22080478
Invest Ophthalmol Vis Sci. 2016 Oct 01;57(13):5429-5434
pubmed: 27756077
PLoS One. 2020 Dec 1;15(12):e0242667
pubmed: 33259500
Ophthalmology. 2012 Dec;119(12):2572-8
pubmed: 22921388
Invest Ophthalmol Vis Sci. 2014 May 13;55(6):3851-6
pubmed: 24825109
Acta Ophthalmol. 2014 Jun;92(4):328-31
pubmed: 23848230
Graefes Arch Clin Exp Ophthalmol. 2009 Aug;247(8):1025-30
pubmed: 19404666
Invest Ophthalmol Vis Sci. 2014 Oct 09;55(11):7104-10
pubmed: 25301879
Acta Ophthalmol. 2019 May;97(3):296-302
pubmed: 30843354
Retina. 2021 Sep 1;41(9):1839-1850
pubmed: 33512895
Retina. 2018 Aug;38(8):1571-1580
pubmed: 28671896
Am J Ophthalmol. 2016 May;165:100-7
pubmed: 26970574
Ophthalmic Surg Lasers Imaging Retina. 2019 Apr 1;50(4):e105-e111
pubmed: 30998253
J Biomed Opt. 2008 Sep-Oct;13(5):054015
pubmed: 19021395
Acta Ophthalmol. 2014 Mar;92(2):105-10
pubmed: 23323611
Arch Ophthalmol. 2009 Apr;127(4):475-82
pubmed: 19365028
Retina. 2020 Nov;40(11):2184-2190
pubmed: 31842192
Retina. 2010 Jan;30(1):117-24
pubmed: 19996831
Acta Ophthalmol Scand. 2006 Dec;84(6):812-4
pubmed: 17083544
Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):261-6
pubmed: 22167095
Invest Ophthalmol Vis Sci. 1996 May;37(6):1140-8
pubmed: 8631628
Invest Ophthalmol Vis Sci. 2011 Aug 16;52(9):6409-13
pubmed: 21715353
Retina. 2019 Mar;39(3):601-607
pubmed: 29215533
Acta Ophthalmol. 2015 Sep;93(6):e439-45
pubmed: 25430037
Ophthalmologica. 2017;237(2):78-84
pubmed: 28245442
Am J Ophthalmol. 2009 May;147(5):869-74, 874.e1
pubmed: 19200531
Invest Ophthalmol Vis Sci. 2017 May 1;58(5):2498-2502
pubmed: 28470332
Graefes Arch Clin Exp Ophthalmol. 2016 Feb;254(2):243-52
pubmed: 25952041
Invest Ophthalmol Vis Sci. 2014 Nov 04;55(11):7594-600
pubmed: 25370511
Am J Ophthalmol. 2000 Dec;130(6):732-9
pubmed: 11124291
Am J Ophthalmol. 2005 Feb;139(2):302-10
pubmed: 15733992
Acta Ophthalmol. 2017 Aug;95(5):e393-e398
pubmed: 27229756
J Cataract Refract Surg. 2014 Feb;40(2):184-91
pubmed: 24360848
Invest Ophthalmol Vis Sci. 2014 Jul 22;55(8):4967-74
pubmed: 25052991
Graefes Arch Clin Exp Ophthalmol. 2016 Jun;254(6):1059-67
pubmed: 26338821
Arch Ophthalmol. 1980 Jul;98(7):1248-52
pubmed: 7396778
Invest Ophthalmol Vis Sci. 2013 Mar 21;54(3):2028-34
pubmed: 23439600
Eye (Lond). 2008 Oct;22(10):1337-41
pubmed: 18437175
Invest Ophthalmol Vis Sci. 2006 Nov;47(11):5011-6
pubmed: 17065521
Graefes Arch Clin Exp Ophthalmol. 2009 Feb;247(2):147-63
pubmed: 19034481

Auteurs

Günther Weigert (G)

Department of Ophthalmology, Medical University of Vienna, Vienna, Austria.

Michael Georgopoulos (M)

Department of Ophthalmology, Medical University of Vienna, Vienna, Austria.

Wolf Buehl (W)

Department of Ophthalmology, Medical University of Vienna, Vienna, Austria.
Vienna Clinical Trial Center, Medical University of Vienna, Vienna, Austria.

Katia Maccora (K)

Department of Ophthalmology, Medical University of Vienna, Vienna, Austria.
Vienna Clinical Trial Center, Medical University of Vienna, Vienna, Austria.

Leyla Aliyeva (L)

Department of Ophthalmology, Medical University of Vienna, Vienna, Austria.
Vienna Clinical Trial Center, Medical University of Vienna, Vienna, Austria.

Irene Steiner (I)

CeMSIIS, Center for Medical Statistics, Informatics and Intelligent Systems, Section for Medical Statistics, Medical University of Vienna, Vienna, Austria.

Ursula Schmidt-Erfurth (U)

Department of Ophthalmology, Medical University of Vienna, Vienna, Austria.

Stefan Sacu (S)

Department of Ophthalmology, Medical University of Vienna, Vienna, Austria.
Vienna Clinical Trial Center, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH